Literature DB >> 9038181

Identification of functional domains in the neuronal Cdk5 activator protein.

R Y Poon1, J Lew, T Hunter.   

Abstract

Cyclin-dependent kinase 5 (Cdk5) is activated by the neuronal-specific activator protein, p35. In contrast to the activation of typical CDKs by cyclin subunits, p35.Cdk5 was not further activated by the CDK-activating kinase (CAK) and was neither phosphorylated nor inhibited by the Tyr-15-specific Wee1 kinase. The previously identified proteolytic active fragment of p35, p25 (residues 91-307) as well as the slightly smaller fragment containing residues 109-291, was found to be sufficient to bind and activate Cdk5. Other CDKs, including Cdk2, associated weakly with p25. However, their kinase activity was only activated to the low level observed for cyclin A.Cdk2 without Thr-160 phosphorylation, and phosphorylation of Thr-160 in Cdk2 did not activate the p25.Cdk2 complex further. We have identified distinct regions in p35 required for binding to Cdk5 or activation of Cdk5. Residues approximately 150-200 of p35 were sufficient for binding to Cdk5, but residues approximately 279-291 were needed in addition for activation of Cdk5 in vitro.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9038181     DOI: 10.1074/jbc.272.9.5703

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Sumoylation of p35 modulates p35/cyclin-dependent kinase (Cdk) 5 complex activity.

Authors:  Anja Büchner; Petranka Krumova; Sundar Ganesan; Mathias Bähr; Katrin Eckermann; Jochen H Weishaupt
Journal:  Neuromolecular Med       Date:  2014-11-13       Impact factor: 3.843

2.  Structure of the Pho85-Pho80 CDK-cyclin complex of the phosphate-responsive signal transduction pathway.

Authors:  Kexin Huang; Ian Ferrin-O'Connell; Wei Zhang; Gordon A Leonard; Erin K O'Shea; Florante A Quiocho
Journal:  Mol Cell       Date:  2007-11-30       Impact factor: 17.970

3.  Akt-mediated phosphorylation of CDK2 regulates its dual role in cell cycle progression and apoptosis.

Authors:  Subbareddy Maddika; Sudharsana Rao Ande; Emilia Wiechec; Lise Lotte Hansen; Sebastian Wesselborg; Marek Los
Journal:  J Cell Sci       Date:  2008-04-01       Impact factor: 5.285

4.  New structural insights into phosphorylation-free mechanism for full cyclin-dependent kinase (CDK)-cyclin activity and substrate recognition.

Authors:  Fei Zheng; Florante A Quiocho
Journal:  J Biol Chem       Date:  2013-09-10       Impact factor: 5.157

5.  Identification and characterization of a novel phosphoregulatory site on cyclin-dependent kinase 5.

Authors:  Brett Lee Roach; Jordan Matthew Ngo; Clariss Limso; Koyinsola Bolutife Oloja; Deepali Bhandari
Journal:  Biochem Biophys Res Commun       Date:  2018-09-11       Impact factor: 3.575

6.  Structural and dynamic determinants of ligand binding and regulation of cyclin-dependent kinase 5 by pathological activator p25 and inhibitory peptide CIP.

Authors:  A Cardone; S A Hassan; R W Albers; R D Sriram; H C Pant
Journal:  J Mol Biol       Date:  2010-06-25       Impact factor: 5.469

7.  Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation.

Authors:  P Sharma; M Sharma; N D Amin; R W Albers; H C Pant
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

8.  Characterization of the CDK5 gene in Apis cerana cerana (AccCDK5) and a preliminary identification of its activator gene, AccCDK5r1.

Authors:  Guangdong Zhao; Chen Wang; Hongfang Wang; Lijun Gao; Zhenguo Liu; Baohua Xu; Xingqi Guo
Journal:  Cell Stress Chaperones       Date:  2017-07-03       Impact factor: 3.667

9.  Regulation of cyclin A-Cdk2 by SCF component Skp1 and F-box protein Skp2.

Authors:  C H Yam; R W Ng; W Y Siu; A W Lau; R Y Poon
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

10.  Unscheduled Akt-triggered activation of cyclin-dependent kinase 2 as a key effector mechanism of apoptin's anticancer toxicity.

Authors:  Subbareddy Maddika; Soumya Panigrahi; Emilia Wiechec; Sebastian Wesselborg; Ute Fischer; Klaus Schulze-Osthoff; Marek Los
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.